Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 14001-14050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06741982
A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
PHASE1Recruiting
21 participants
Started: Dec 15, 2024 · Completed: Dec 15, 2026
5 conditions1 sponsor1 location
NCT06687434
Carb Counting vs. Simplified Qualitative Meal-Size Estimation
NARecruiting
120 participants
Started: Dec 15, 2024 · Completed: Dec 15, 2027
1 condition1 sponsor1 location
NCT06552936
Combination Therapy Effect of Laser on Wound Healing and Bone Regeneration of Dental Sockets
NARecruiting
44 participants
Started: Dec 15, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT07074912
Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department
NARecruiting
440 participants
Started: Dec 15, 2024 · Completed: Mar 15, 2026
1 condition1 sponsor1 location
NCT06274788
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
N/ARecruiting
40 participants
Started: Dec 15, 2024 · Completed: Mar 1, 2027
4 conditions1 sponsor10 locations
NCT06628206
Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
PHASE1Recruiting
48 participants
Started: Dec 15, 2024 · Completed: Jan 15, 2026
2 conditions1 sponsor1 location
NCT06547151
Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults
PHASE2Recruiting
81 participants
Started: Dec 15, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor8 locations
NCT06716658
JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/refractory Indolent T/NK-cell Lymphomas
PHASE2Recruiting
48 participants
Started: Dec 15, 2024 · Completed: Nov 15, 2028
10 conditions8 sponsors2 locations
NCT06985836
Effect of Mulligan Mobilization With or Without Niel Asher Technique in Patients With Adhesive Capsulitis
NARecruiting
42 participants
Started: Dec 15, 2024 · Completed: Jun 15, 2025
1 condition1 sponsor1 location
NCT06985849
Effects of Feldenkrais and Otago Exercise Protocols for Mechanical Low Back Pain
NARecruiting
36 participants
Started: Dec 15, 2024 · Completed: Jun 15, 2025
1 condition1 sponsor1 location
NCT06289569
Home Tele Rehabilitation Therapy for Vascular Dementia
NARecruiting
120 participants
Started: Dec 14, 2024 · Completed: Apr 1, 2026
2 conditions1 sponsor1 location
NCT06738862
[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
N/ARecruiting
55 participants
Started: Dec 14, 2024 · Completed: Dec 25, 2025
5 conditions2 sponsors1 location
NCT06705829
Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.
N/ARecruiting
100 participants
Started: Dec 14, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT07132879
Telehealth in MND-Research (TIM-R): A Research Database for MND
N/ARecruiting
1,000 participants
Started: Dec 14, 2024 · Completed: Dec 14, 2074
1 condition2 sponsors1 location
NCT07063537
Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
NARecruiting
60 participants
Started: Dec 14, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06673303
Investigating The Role of Noise Correlations in Learning
NARecruiting
40 participants
Started: Dec 14, 2024 · Completed: Sep 1, 2025
2 conditions2 sponsors1 location
NCT06750133
Universal CNK-UT Therapy for Refractory aGVHD
PHASE1Recruiting
23 participants
Started: Dec 14, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors2 locations
NCT07031544
Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
NARecruiting
60 participants
Started: Dec 14, 2024 · Completed: Mar 31, 2027
1 condition10 sponsors10 locations
NCT06115603
The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
PHASE2Recruiting
76 participants
Started: Dec 14, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06621563
Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors
PHASE1Recruiting
780 participants
Started: Dec 14, 2024 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT06581939
Impact of an Early and Extended Rehabilitation Program Combining Individually Tailored Nutrition and Physical Activities on Patient Outcomes After Invasive Mechanical Ventilation and Vasopressor Therapy in the ICU
NARecruiting
830 participants
Started: Dec 14, 2024 · Completed: Dec 14, 2027
1 condition1 sponsor51 locations
NCT06781567
Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma
PHASE2Recruiting
140 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT06710847
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
PHASE1/PHASE2Recruiting
73 participants
Started: Dec 13, 2024 · Completed: Jun 16, 2028
5 conditions2 sponsors13 locations
NCT06532422
Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy
N/ARecruiting
50 participants
Started: Dec 13, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06724159
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
N/ARecruiting
500 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors76 locations
NCT06240325
Sleep Promotion Program Primary Care
NARecruiting
100 participants
Started: Dec 13, 2024 · Completed: Mar 31, 2026
3 conditions2 sponsors1 location
NCT06639451
A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)
NARecruiting
186 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor8 locations
NCT06777433
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
PHASE2Recruiting
30 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors5 locations
NCT06635889
Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain
PHASE2Recruiting
116 participants
Started: Dec 13, 2024 · Completed: Oct 31, 2029
1 condition1 sponsor1 location
NCT06734000
Cohorte COSCINUS - Biocollection
N/ARecruiting
105 participants
Started: Dec 13, 2024 · Completed: Oct 10, 2032
1 condition1 sponsor1 location
NCT06008730
Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer
PHASE2Recruiting
20 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06201234
Evaluating the Addition of Elacestrant (oral SERD) to Olaparib (PARP-inhibitor) in Patients with Advanced/metastatic HR+/HER2- Breast Cancer
PHASE2Recruiting
176 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2028
4 conditions2 sponsors2 locations
NCT06657222
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
130 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2028
6 conditions1 sponsor13 locations
NCT06394830
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
PHASE2Recruiting
50 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors5 locations
NCT06557512
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
NARecruiting
23 participants
Started: Dec 13, 2024 · Completed: Sep 30, 2029
3 conditions2 sponsors1 location
NCT06666764
Normobaric Oxygen in AIS Transferred for EVT
PHASE3Recruiting
1,500 participants
Started: Dec 13, 2024 · Completed: Oct 31, 2027
1 condition1 sponsor2 locations
NCT06732141
Remote Anxiety Management for ICS-resistant Asthma Study
NARecruiting
216 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor4 locations
NCT06599931
Cerebello-motor Neuromodulation After Stroke. CERSTIM.
NARecruiting
45 participants
Started: Dec 13, 2024 · Completed: Dec 30, 2027
2 conditions1 sponsor2 locations
NCT06663072
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
PHASE1Recruiting
25 participants
Started: Dec 13, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT06675955
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
PHASE3Recruiting
500 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor21 locations
NCT06740266
The Impact of an Evidence-Based Parenting Service on Maternal Sensitivity and Infant Cellular Aging in a Population of Under-Resourced Families
NARecruiting
250 participants
Started: Dec 13, 2024 · Completed: Apr 30, 2029
4 conditions3 sponsors1 location
NCT06696573
Effectiveness of Anti-Inflammatory Drugs for Preventing Pain Versus Treating Pain During Medical Abortion From 13 to 22 Weeks at Hung Vuong Hospital
NARecruiting
180 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06736327
A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects with Advanced Solid Tumors
PHASE1Recruiting
180 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06734832
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
PHASE3Recruiting
8,000 participants
Started: Dec 13, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor4 locations
NCT06731530
Corneal Biomechanics, Optical Properties and Anterior Segment Structural Features in Patients With Pseudoexfoliation
N/ARecruiting
86 participants
Started: Dec 13, 2024 · Completed: May 31, 2025
3 conditions2 sponsors1 location
NCT06764069
Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor
NARecruiting
10 participants
Started: Dec 13, 2024 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT06745557
Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
PHASE3Recruiting
70 participants
Started: Dec 13, 2024 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT06441214
Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.
N/ARecruiting
125 participants
Started: Dec 13, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor28 locations
NCT06740370
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
NARecruiting
32 participants
Started: Dec 13, 2024 · Completed: Aug 30, 2026
4 conditions1 sponsor1 location
NCT07125131
Gamification-Enhanced Problem-Based Learning
NARecruiting
100 participants
Started: Dec 13, 2024 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location